0.027123 0.000000 0.000000 0.000000 0.016315 0.000000 0.000000 0.000000 0.013890 0.00000 0.00000 0.00000 VAL C 5 - LEU C 6 OMEGA = 359.98 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION Mikol, V. Kallen, J. Walkinshaw, M.D. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 4 90.00 90.00 90.00 36.869 61.292 71.993 C4 H9 N O2 103.120 n ALPHA-AMINOBUTYRIC ACID L-peptide linking C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C10 H19 N O3 201.263 n 4-METHYL-4-[(E)-2-BUTENYL]-4,N-METHYL-THREONINE L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C3 H7 N O2 89.093 D-ALANINE D-peptide linking C11 H21 N O3 215.289 3-HYDROXY-4,4-DIMETHYL-2-(METHYLAMINO)-6-OCTENOIC ACID L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking H2 O 18.015 WATER non-polymer C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C7 H15 N O2 145.199 n N-METHYLLEUCINE L-peptide linking C6 H13 N O2 131.173 n N-METHYLVALINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O2 89.093 n SARCOSINE peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking UK Protein Eng. PRENE9 0859 0269-2139 7 597 10.1093/PROTEIN/7.5.597 8073029 The X-Ray Structure of (Mebm2T)1-Cyclosporin Complexed with Cyclophilin a Provides an Explanation for its Anomalously High Immunosuppressive Activity. 1994 DK Acta Crystallogr.,Sect.D ABCRE6 0766 0907-4449 50 543 10.1107/S0907444994001800 15299416 Crystallization of the Complex between Cyclophilin a and Cyclosporin Derivatives: The Use of Cross- Seeding. 1994 US J.Med.Chem. JMCMAR 0151 0022-2623 37 3674 7966126 Improved Binding Affinity for Cyclophilin a by a Cyclosporin Derivative Singly Modified at its Effector Domain. 1994 UK J.Mol.Biol. JMOBAK 0070 0022-2836 234 1119 10.1006/JMBI.1993.1664 8263916 X-Ray Structure of a Monomeric Cyclophilin A- Cyclosporin a Crystal Complex at 2.1 A Resolution. 1993 UK Nature NATUAS 0006 0028-0836 361 91 10.1038/361091A0 8421501 X-Ray Structure of a Decameric Cyclophilin- Cyclosporin Crystal Complex. 1993 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 1 x-ray 1 1.0 18036.504 PEPTIDYL-PROLYL CIS-TRANS ISOMERASE A 5.2.1.8 1 man polymer 4-[(E)-2-BUTENYL]-4,4, N-TRIMETHYL- L-THREONINE AT POSITION 5 1234.651 CYCLOSPORIN A YES 1 syn polymer 18.015 water 131 nat water PPIASE, ROTAMASE, CYCLOPHILIN A CYCLOSPORINE, CICLOSPORIN, CICLOSPORINE no no MVNPTVFFDIAVDGEPLGRVSFELFADKVPKTAENFRALSTGEKGFGYKGSCFHRIIPGFMCQGGDFTRHNGTGGKSIYG EKFEDENFILKHTGPGILSMANAGPNTNGSQFFICTAKTEWLDGKHVVFGKVKEGMNIVEAMERFGSRNGKTSKKITIAD CGQLE MVNPTVFFDIAVDGEPLGRVSFELFADKVPKTAENFRALSTGEKGFGYKGSCFHRIIPGFMCQGGDFTRHNGTGGKSIYG EKFEDENFILKHTGPGILSMANAGPNTNGSQFFICTAKTEWLDGKHVVFGKVKEGMNIVEAMERFGSRNGKTSKKITIAD CGQLE A polypeptide(L) no yes (DAL)(MLE)(MLE)(MVA)(DMT)(ABA)(SAR)(MLE)V(MLE)A ALLVXAGLVLA C polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n HUMAN sample CYCLOPHILIN 9606 HOMO SAPIENS CYCLOPHILIN 562 ESCHERICHIA COLI 2.11 41.70 repository Initial release Version format compliance Version format compliance Atomic model Database references Derived calculations Non-polymer description Structure summary Other 1 0 1996-01-29 1 1 2011-06-14 1 2 2011-07-13 1 3 2011-07-27 1 4 2012-12-12 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH CYCLOSPORIN C CRYSTAL STRUCTURE OF THE CYCLOPHILIN-LIKE DOMAIN FROM BRUGIA MALAYI COMPLEXED WITH CYCLOSPORIN A SOLUTION STRUCTURE OF E.COLI CYCLOPHILIN (F112W) COMPLEXED WITH CYCLOSPORIN A CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH CYCLOSPORIN A CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED CYCLOSPORIN A AT POSITION 8 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH CYCLOSPORIN D CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH CYCLOSPORIN A MODIFIED AT POSITION 7 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED CYCLOSPORIN D AT POSITION 7 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED CYCLOSPORIN D AT POSITIONS 5 AND 7. CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED CYCLOSPORIN D AT POSITIONS 5 AND 7. CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED CYCLOSPORIN A AT POSITION 8 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED CYCLOSPORIN A AT POSITION 8 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH NODIFIED CYCLOSPORIN C AT POSITIONS 1, AND 9 SOLUTION STRUCTURE OF HUMAN CYCLOPHILIN COMPLEXED WIYH CYCLOSPORIN A SOLUTION STRUCTURE OF HUMAN CYCLOPHILIN COMPLEXED WITH CYCLOSPORIN A CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN B COMPLEXED WITH MODIFIED CYCLOSPORIN A CRYSTAL STRUCTURE OF CTCLOSPORIN-FAB COMPLEX CRYSTAL STRUCTURE OF CALCINEURIN-CYCLOPHILIN-CYCLOSPORIN COMPLEX CRYSTAL STRUCTURE OF HUMAN CALCINEURIN COMPLEXED WITH HUMAN CYCLOPHILIN AND CYCLOSPORIN A CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED CYCLOSPORIN A AT POSITION 6 CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM CYCLOPHILIN COMPLEXED WITH CYCLOSPORIN A CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM CYCLOPHILIN (DOUBLE MUTANT) COMPLEXED WITH CYCLOSPORIN A CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYCLOPHILIN COMPLEXED WITH CYCLOSPORIN A CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN C COMPLEXED WITH CYCLOSPORIN A CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN J COMPLEXED WITH CYCLOSPORIN A CRYSTAL STRUCTURE OF CRYPTOSPORIDIUM PARVUM IOWA II CYCLOPHILIN A COMPLEXED WITH CYCLOSPORIN A CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH CYCLOSPORIN A CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED CYCLOSPORIN A AT POSITION 5 CRYSTAL STRUCTURE OF MURINE CYCLOPHILIN C COMPLEXED WITH CYCLOSPORIN A CRYSTAL STRUCTURE OF THE PPIASE DOMAIN OF HUMAN CYCLOPHILIN G COMPLEXED WITH CYCLOSPORIN A CRYSTAL STRUCTURE OF HUMAN ACETYL-CYPA COMPLEXED WITH CYCLOSPORINE A CRYSTAL STRUCTURE OF PPIL1 COMPLEXED WITH CYCLOSPORINE A CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN D IN COMPLEX WITH CYCLOSPORIN A CRYSTAL STRUCTURE OF CYCLOSPHILIN A FROM TOXOPLASMA GONDII COMPLEXED WIT CYCLOSPORIN A SOLUTION STRUCTURE OF THE HUMAN CYCLOSPORIN A COMPLEXED WITH CYCLOSPORIN A CRYSTAL STRUCTURE OF CYCLOPHILIN FROM LEISHMANIA DONOVANI COMPLEXED WITH CYCLOSPORIN A Y 1995-09-06 REL HOH water 29910 TOLYPOCLADIUM INFLATUM sample CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE. HERE, CYCLOSPORIN A IS REPRESENTED BY THE SEQUENCE (SEQRES) Immunosuppressant CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE. CYCLIZATION IS ACHIEVED BY LINKING THE N- AND THE C- TERMINI. THE CYCLOSPORIN WAS MODIFIED AT POSITION 5 TO BE 4-[(E)-2-BUTENYL]-4,4,N-TRIMETHYL-L-THREONINE CYCLOSPORIN A, 5 mutation Cyclic peptide HOH 2001 3 HOH HOH 2001 A HOH 2002 3 HOH HOH 2002 A HOH 2003 3 HOH HOH 2003 A HOH 2004 3 HOH HOH 2004 A HOH 2005 3 HOH HOH 2005 A HOH 2006 3 HOH HOH 2006 A HOH 2007 3 HOH HOH 2007 A HOH 2008 3 HOH HOH 2008 A HOH 2009 3 HOH HOH 2009 A HOH 2010 3 HOH HOH 2010 A HOH 2011 3 HOH HOH 2011 A HOH 2012 3 HOH HOH 2012 A HOH 2013 3 HOH HOH 2013 A HOH 2014 3 HOH HOH 2014 A HOH 2015 3 HOH HOH 2015 A HOH 2016 3 HOH HOH 2016 A HOH 2017 3 HOH HOH 2017 A HOH 2018 3 HOH HOH 2018 A HOH 2019 3 HOH HOH 2019 A HOH 2020 3 HOH HOH 2020 A HOH 2021 3 HOH HOH 2021 A HOH 2022 3 HOH HOH 2022 A HOH 2023 3 HOH HOH 2023 A HOH 2024 3 HOH HOH 2024 A HOH 2025 3 HOH HOH 2025 A HOH 2026 3 HOH HOH 2026 A HOH 2027 3 HOH HOH 2027 A HOH 2028 3 HOH HOH 2028 A HOH 2029 3 HOH HOH 2029 A HOH 2030 3 HOH HOH 2030 A HOH 2031 3 HOH HOH 2031 A HOH 2032 3 HOH HOH 2032 A HOH 2033 3 HOH HOH 2033 A HOH 2034 3 HOH HOH 2034 A HOH 2035 3 HOH HOH 2035 A HOH 2036 3 HOH HOH 2036 A HOH 2037 3 HOH HOH 2037 A HOH 2038 3 HOH HOH 2038 A HOH 2039 3 HOH HOH 2039 A HOH 2040 3 HOH HOH 2040 A HOH 2041 3 HOH HOH 2041 A HOH 2042 3 HOH HOH 2042 A HOH 2043 3 HOH HOH 2043 A HOH 2044 3 HOH HOH 2044 A HOH 2045 3 HOH HOH 2045 A HOH 2046 3 HOH HOH 2046 A HOH 2047 3 HOH HOH 2047 A HOH 2048 3 HOH HOH 2048 A HOH 2049 3 HOH HOH 2049 A HOH 2050 3 HOH HOH 2050 A HOH 2051 3 HOH HOH 2051 A HOH 2052 3 HOH HOH 2052 A HOH 2053 3 HOH HOH 2053 A HOH 2054 3 HOH HOH 2054 A HOH 2055 3 HOH HOH 2055 A HOH 2056 3 HOH HOH 2056 A HOH 2057 3 HOH HOH 2057 A HOH 2058 3 HOH HOH 2058 A HOH 2059 3 HOH HOH 2059 A HOH 2060 3 HOH HOH 2060 A HOH 2061 3 HOH HOH 2061 A HOH 2062 3 HOH HOH 2062 A HOH 2063 3 HOH HOH 2063 A HOH 2064 3 HOH HOH 2064 A HOH 2065 3 HOH HOH 2065 A HOH 2066 3 HOH HOH 2066 A HOH 2067 3 HOH HOH 2067 A HOH 2068 3 HOH HOH 2068 A HOH 2069 3 HOH HOH 2069 A HOH 2070 3 HOH HOH 2070 A HOH 2071 3 HOH HOH 2071 A HOH 2072 3 HOH HOH 2072 A HOH 2073 3 HOH HOH 2073 A HOH 2074 3 HOH HOH 2074 A HOH 2075 3 HOH HOH 2075 A HOH 2076 3 HOH HOH 2076 A HOH 2077 3 HOH HOH 2077 A HOH 2078 3 HOH HOH 2078 A HOH 2079 3 HOH HOH 2079 A HOH 2080 3 HOH HOH 2080 A HOH 2081 3 HOH HOH 2081 A HOH 2082 3 HOH HOH 2082 A HOH 2083 3 HOH HOH 2083 A HOH 2084 3 HOH HOH 2084 A HOH 2085 3 HOH HOH 2085 A HOH 2086 3 HOH HOH 2086 A HOH 2087 3 HOH HOH 2087 A HOH 2088 3 HOH HOH 2088 A HOH 2089 3 HOH HOH 2089 A HOH 2090 3 HOH HOH 2090 A HOH 2091 3 HOH HOH 2091 A HOH 2092 3 HOH HOH 2092 A HOH 2093 3 HOH HOH 2093 A HOH 2094 3 HOH HOH 2094 A HOH 2095 3 HOH HOH 2095 A HOH 2096 3 HOH HOH 2096 A HOH 2097 3 HOH HOH 2097 A HOH 2098 3 HOH HOH 2098 A HOH 2099 3 HOH HOH 2099 A HOH 2100 3 HOH HOH 2100 A HOH 2101 3 HOH HOH 2101 A HOH 2102 3 HOH HOH 2102 A HOH 2103 3 HOH HOH 2103 A HOH 2104 3 HOH HOH 2104 A HOH 2105 3 HOH HOH 2105 A HOH 2106 3 HOH HOH 2106 A HOH 2107 3 HOH HOH 2107 A HOH 2108 3 HOH HOH 2108 A HOH 2109 3 HOH HOH 2109 A HOH 2110 3 HOH HOH 2110 A HOH 2111 3 HOH HOH 2111 A HOH 2112 3 HOH HOH 2112 A HOH 2113 3 HOH HOH 2113 A HOH 2114 3 HOH HOH 2114 A HOH 2115 3 HOH HOH 2115 A HOH 2116 3 HOH HOH 2116 A HOH 2117 3 HOH HOH 2117 A HOH 2118 3 HOH HOH 2118 A HOH 2119 3 HOH HOH 2119 A HOH 2120 3 HOH HOH 2120 A HOH 2121 3 HOH HOH 2121 A HOH 2122 3 HOH HOH 2122 A HOH 2123 3 HOH HOH 2123 A HOH 2124 3 HOH HOH 2124 A HOH 2125 3 HOH HOH 2125 A HOH 2126 3 HOH HOH 2126 A HOH 2001 3 HOH HOH 2001 C HOH 2002 3 HOH HOH 2002 C HOH 2003 3 HOH HOH 2003 C HOH 2004 3 HOH HOH 2004 C HOH 2005 3 HOH HOH 2005 C MET 1 n 1 MET 1 A VAL 2 n 2 VAL 2 A ASN 3 n 3 ASN 3 A PRO 4 n 4 PRO 4 A THR 5 n 5 THR 5 A VAL 6 n 6 VAL 6 A PHE 7 n 7 PHE 7 A PHE 8 n 8 PHE 8 A ASP 9 n 9 ASP 9 A ILE 10 n 10 ILE 10 A ALA 11 n 11 ALA 11 A VAL 12 n 12 VAL 12 A ASP 13 n 13 ASP 13 A GLY 14 n 14 GLY 14 A GLU 15 n 15 GLU 15 A PRO 16 n 16 PRO 16 A LEU 17 n 17 LEU 17 A GLY 18 n 18 GLY 18 A ARG 19 n 19 ARG 19 A VAL 20 n 20 VAL 20 A SER 21 n 21 SER 21 A PHE 22 n 22 PHE 22 A GLU 23 n 23 GLU 23 A LEU 24 n 24 LEU 24 A PHE 25 n 25 PHE 25 A ALA 26 n 26 ALA 26 A ASP 27 n 27 ASP 27 A LYS 28 n 28 LYS 28 A VAL 29 n 29 VAL 29 A PRO 30 n 30 PRO 30 A LYS 31 n 31 LYS 31 A THR 32 n 32 THR 32 A ALA 33 n 33 ALA 33 A GLU 34 n 34 GLU 34 A ASN 35 n 35 ASN 35 A PHE 36 n 36 PHE 36 A ARG 37 n 37 ARG 37 A ALA 38 n 38 ALA 38 A LEU 39 n 39 LEU 39 A SER 40 n 40 SER 40 A THR 41 n 41 THR 41 A GLY 42 n 42 GLY 42 A GLU 43 n 43 GLU 43 A LYS 44 n 44 LYS 44 A GLY 45 n 45 GLY 45 A PHE 46 n 46 PHE 46 A GLY 47 n 47 GLY 47 A TYR 48 n 48 TYR 48 A LYS 49 n 49 LYS 49 A GLY 50 n 50 GLY 50 A SER 51 n 51 SER 51 A CYS 52 n 52 CYS 52 A PHE 53 n 53 PHE 53 A HIS 54 n 54 HIS 54 A ARG 55 n 55 ARG 55 A ILE 56 n 56 ILE 56 A ILE 57 n 57 ILE 57 A PRO 58 n 58 PRO 58 A GLY 59 n 59 GLY 59 A PHE 60 n 60 PHE 60 A MET 61 n 61 MET 61 A CYS 62 n 62 CYS 62 A GLN 63 n 63 GLN 63 A GLY 64 n 64 GLY 64 A GLY 65 n 65 GLY 65 A ASP 66 n 66 ASP 66 A PHE 67 n 67 PHE 67 A THR 68 n 68 THR 68 A ARG 69 n 69 ARG 69 A HIS 70 n 70 HIS 70 A ASN 71 n 71 ASN 71 A GLY 72 n 72 GLY 72 A THR 73 n 73 THR 73 A GLY 74 n 74 GLY 74 A GLY 75 n 75 GLY 75 A LYS 76 n 76 LYS 76 A SER 77 n 77 SER 77 A ILE 78 n 78 ILE 78 A TYR 79 n 79 TYR 79 A GLY 80 n 80 GLY 80 A GLU 81 n 81 GLU 81 A LYS 82 n 82 LYS 82 A PHE 83 n 83 PHE 83 A GLU 84 n 84 GLU 84 A ASP 85 n 85 ASP 85 A GLU 86 n 86 GLU 86 A ASN 87 n 87 ASN 87 A PHE 88 n 88 PHE 88 A ILE 89 n 89 ILE 89 A LEU 90 n 90 LEU 90 A LYS 91 n 91 LYS 91 A HIS 92 n 92 HIS 92 A THR 93 n 93 THR 93 A GLY 94 n 94 GLY 94 A PRO 95 n 95 PRO 95 A GLY 96 n 96 GLY 96 A ILE 97 n 97 ILE 97 A LEU 98 n 98 LEU 98 A SER 99 n 99 SER 99 A MET 100 n 100 MET 100 A ALA 101 n 101 ALA 101 A ASN 102 n 102 ASN 102 A ALA 103 n 103 ALA 103 A GLY 104 n 104 GLY 104 A PRO 105 n 105 PRO 105 A ASN 106 n 106 ASN 106 A THR 107 n 107 THR 107 A ASN 108 n 108 ASN 108 A GLY 109 n 109 GLY 109 A SER 110 n 110 SER 110 A GLN 111 n 111 GLN 111 A PHE 112 n 112 PHE 112 A PHE 113 n 113 PHE 113 A ILE 114 n 114 ILE 114 A CYS 115 n 115 CYS 115 A THR 116 n 116 THR 116 A ALA 117 n 117 ALA 117 A LYS 118 n 118 LYS 118 A THR 119 n 119 THR 119 A GLU 120 n 120 GLU 120 A TRP 121 n 121 TRP 121 A LEU 122 n 122 LEU 122 A ASP 123 n 123 ASP 123 A GLY 124 n 124 GLY 124 A LYS 125 n 125 LYS 125 A HIS 126 n 126 HIS 126 A VAL 127 n 127 VAL 127 A VAL 128 n 128 VAL 128 A PHE 129 n 129 PHE 129 A GLY 130 n 130 GLY 130 A LYS 131 n 131 LYS 131 A VAL 132 n 132 VAL 132 A LYS 133 n 133 LYS 133 A GLU 134 n 134 GLU 134 A GLY 135 n 135 GLY 135 A MET 136 n 136 MET 136 A ASN 137 n 137 ASN 137 A ILE 138 n 138 ILE 138 A VAL 139 n 139 VAL 139 A GLU 140 n 140 GLU 140 A ALA 141 n 141 ALA 141 A MET 142 n 142 MET 142 A GLU 143 n 143 GLU 143 A ARG 144 n 144 ARG 144 A PHE 145 n 145 PHE 145 A GLY 146 n 146 GLY 146 A SER 147 n 147 SER 147 A ARG 148 n 148 ARG 148 A ASN 149 n 149 ASN 149 A GLY 150 n 150 GLY 150 A LYS 151 n 151 LYS 151 A THR 152 n 152 THR 152 A SER 153 n 153 SER 153 A LYS 154 n 154 LYS 154 A LYS 155 n 155 LYS 155 A ILE 156 n 156 ILE 156 A THR 157 n 157 THR 157 A ILE 158 n 158 ILE 158 A ALA 159 n 159 ALA 159 A ASP 160 n 160 ASP 160 A CYS 161 n 161 CYS 161 A GLY 162 n 162 GLY 162 A GLN 163 n 163 GLN 163 A LEU 164 n 164 LEU 164 A GLU 165 n 165 GLU 165 A DAL 1 n 1 DAL 1 C MLE 2 n 2 MLE 2 C MLE 3 n 3 MLE 3 C MVA 4 n 4 MVA 4 C DMT 5 n 5 DMT 5 C ABA 6 n 6 ABA 6 C SAR 7 n 7 SAR 7 C MLE 8 n 8 MLE 8 C VAL 9 n 9 VAL 9 C MLE 10 n 10 MLE 10 C ALA 11 n 11 ALA 11 C author_and_software_defined_assembly PISA 2 dimeric 1020 -8.0 7840 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A N ILE 57 A N ILE 57 A O MET 61 A O MET 61 A N GLY 64 A N GLY 64 A O PHE 112 A O PHE 112 A N CYS 115 A N CYS 115 A O ILE 97 A O ILE 97 A O LEU 98 A O LEU 98 A N PHE 129 A N PHE 129 A N LYS 133 A N LYS 133 A O SER 21 A O SER 21 A N PHE 22 A N PHE 22 A O VAL 6 A O VAL 6 A N ALA 11 A N ALA 11 A O THR 157 A O THR 157 1 6.13 0.50 120.30 126.43 A A A NE CZ NH1 ARG ARG ARG 19 19 19 N 1 -5.01 0.50 120.30 115.29 A A A NE CZ NH2 ARG ARG ARG 19 19 19 N 1 3.07 0.50 120.30 123.37 A A A NE CZ NH1 ARG ARG ARG 37 37 37 N 1 -10.50 1.60 100.20 89.70 A A A CG SD CE MET MET MET 61 61 61 N 1 12.35 1.60 100.20 112.55 A A A CG SD CE MET MET MET 100 100 100 N 1 6.71 0.80 106.30 113.01 A A A CD1 CG CD2 TRP TRP TRP 121 121 121 N 1 -6.20 0.80 107.30 101.10 A A A CE2 CD2 CG TRP TRP TRP 121 121 121 N 1 3.07 0.50 120.30 123.37 A A A NE CZ NH1 ARG ARG ARG 144 144 144 N 1 -3.69 0.50 120.30 116.61 A A A NE CZ NH2 ARG ARG ARG 148 148 148 N 1 A A NE2 CD2 HIS HIS 54 54 -0.076 0.011 1.373 1.297 N 1 A A NE2 CD2 HIS HIS 70 70 -0.068 0.011 1.373 1.305 N 1 A A NE2 CD2 HIS HIS 92 92 -0.068 0.011 1.373 1.305 N 1 A PHE 60 -120.85 -75.04 0.162 0.162 2.20 8.00 1 2.000 2.20 8.00 131 1483 0 0 1352 0.013 2.70 2.200 15.000 1CWB 7343 2.000 1 84.2 model building X-PLOR refinement X-PLOR phasing X-PLOR PEPTIDYL-PROLYL CIS-TRANS ISOMERASE A (E.C.5.2.1.8), CYCLOSPORIN A THE X-RAY STRUCTURE OF (MEBM2T)1-CYCLOSPORIN COMPLEXED WITH CYCLOPHILIN A PROVIDES AN EXPLANATION FOR ITS ANOMALOUSLY HIGH IMMUNOSUPPRESSIVE ACTIVITY 1 N N 2 N N 3 N N 3 N N A VAL 29 A VAL 29 HELX_P A GLY 42 A GLY 42 1 1 14 A THR 119 A THR 119 HELX_P A ASP 123 A ASP 123 5 2 5 A GLY 135 A GLY 135 HELX_P A ARG 144 A ARG 144 1 3 10 covale 1.346 C DAL 1 B C DAL 1 1_555 C MLE 2 B N MLE 2 1_555 covale 1.331 C DAL 1 B N DAL 1 1_555 C ALA 11 B C ALA 11 1_555 covale 1.343 C MLE 2 B C MLE 2 1_555 C MLE 3 B N MLE 3 1_555 covale 1.346 C MLE 3 B C MLE 3 1_555 C MVA 4 B N MVA 4 1_555 covale 1.345 C MVA 4 B C MVA 4 1_555 C DMT 5 B N DMT 5 1_555 covale 1.342 C DMT 5 B C DMT 5 1_555 C ABA 6 B N ABA 6 1_555 covale 1.348 C ABA 6 B C ABA 6 1_555 C SAR 7 B N SAR 7 1_555 covale 1.349 C SAR 7 B C SAR 7 1_555 C MLE 8 B N MLE 8 1_555 covale 1.336 C MLE 8 B C MLE 8 1_555 C VAL 9 B N VAL 9 1_555 covale 1.346 C VAL 9 B C VAL 9 1_555 C MLE 10 B N MLE 10 1_555 covale 1.328 C MLE 10 B C MLE 10 1_555 C ALA 11 B N ALA 11 1_555 ISOMERASE/IMMUNOSUPPRESSANT ISOMERASE-IMMUNOSUPPRESSANT COMPLEX, CYCLOPHILIN-CYCLOSPORIN COMPLEX, CYCLOSPORIN A, IMMUNOSUPPRESSANT, CYCLOPHILIN CYPH_HUMAN UNP 1 P05092 NOR00033 NOR 2 NOR00033 1 164 1CWB 2 165 P05092 A 1 2 165 1 11 1CWB 1 11 NOR00033 C 2 1 11 2 BMT ENGINEERED MUTATION DMT 5 1CWB C NOR00033 NOR 5 5 8 anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel A PHE 53 A PHE 53 A ILE 57 A ILE 57 A MET 61 A MET 61 A GLY 64 A GLY 64 A PHE 112 A PHE 112 A CYS 115 A CYS 115 A ILE 97 A ILE 97 A MET 100 A MET 100 A VAL 128 A VAL 128 A GLU 134 A GLU 134 A GLU 15 A GLU 15 A LEU 24 A LEU 24 A THR 5 A THR 5 A VAL 12 A VAL 12 A ILE 156 A ILE 156 A GLN 163 A GLN 163 BINDING SITE FOR CHAIN C OF CYCLOSPORIN A Software 17 A ARG 19 A ARG 19 17 1_555 A ARG 55 A ARG 55 17 1_555 A PHE 60 A PHE 60 17 1_555 A MET 61 A MET 61 17 1_555 A GLN 63 A GLN 63 17 1_555 A GLY 72 A GLY 72 17 1_555 A ASN 102 A ASN 102 17 1_555 A ALA 103 A ALA 103 17 1_555 A GLN 111 A GLN 111 17 1_555 A PHE 113 A PHE 113 17 1_555 A TRP 121 A TRP 121 17 1_555 A HIS 126 A HIS 126 17 1_555 A LEU 164 A LEU 164 17 1_555 A HOH 2098 C HOH 17 1_555 C HOH 2001 D HOH 17 1_555 C HOH 2004 D HOH 17 1_555 C HOH 2005 D HOH 17 1_555 19 P 21 21 21